uric acid has been researched along with Myocardial Ischemia in 51 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied effects of beta-adrenoblocker carvedilol vs placebo in 60 patients with chronic cardiac failure (CCF) of functional classes III-IV in a 6-month open randomized trial." | 9.10 | [Endothelial protection in patients with apparent cardiac failure in long-term therapy by carvedilol]. ( Shliakhto, EV; Sitnikova, MIu, 2003) |
| "We evaluated the association between serum uric acid (SUA) and atrial fibrillation (AF) in patients with chronic heart failure (HF)." | 7.79 | Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure. ( Erbay, AR; Tekin, G; Tekin, YK; Turhan, H; Yetkin, E, 2013) |
| "Comparison of the serum uric acid levels of healthy people (n=71) and patients with cardiovascular diseases (CVD) (n=62)." | 7.70 | Serum uric acid levels in cardiovascular diseases. ( Burgaz, S; Simsek, B; Torun, M; Yardim, S, 1998) |
| " The serum concentrations of hypoxanthine, xanthine, uric acid and allantoin were determined in peripheral blood samples from patients with angina pectoris, cerebral insult and myocardial infarction with thrombolytic therapy and were compared with the concentrations obtained for healthy males and females." | 7.69 | A comparative study of the concentrations of hypoxanthine, xanthine, uric acid and allantoin in the peripheral blood of normals and patients with acute myocardial infarction and other ischaemic diseases. ( Delvoux, B; Greiling, H; Kock, R; Sigmund, M, 1994) |
| "Allopurinol is a urate-lowering therapy used to treat patients with gout." | 5.51 | Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial. ( Avery, AJ; Barr, RJ; Begg, AG; Duce, SL; Dumbleton, JS; Ford, I; Greenlaw, N; Hawkey, CJ; MacDonald, TM; Mackenzie, IS; Pigazzani, F; Ritchie, LD; Rogers, A; Rooke, ED; Struthers, AD; Taggar, JS; Townend, JN; Walker, A; Wei, L, 2022) |
| "We studied effects of beta-adrenoblocker carvedilol vs placebo in 60 patients with chronic cardiac failure (CCF) of functional classes III-IV in a 6-month open randomized trial." | 5.10 | [Endothelial protection in patients with apparent cardiac failure in long-term therapy by carvedilol]. ( Shliakhto, EV; Sitnikova, MIu, 2003) |
| " The aim of this work was to study the relationship between the Cortisol blood level and the intensity of free radical reactions in patients with acute myocardial ischemia and acute myocardial infarction with respect to metabolic (glucose, uric acid) and enzymatic agents of ischemia and necrosis." | 5.09 | [Cortisol levels in blood of persons with acute myocardial ischemia and myocardial infarction]. ( Domański, L, 1999) |
| " Hyperuricemia was defined as serum uric acid levels exceeding 7." | 4.31 | Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment. ( Jeong, SH; Kho, BG; Kim, TO; Kim, YI; Kwon, YS; Lee, JK; Lim, SC; Na, YO; Shin, HJ; Yoon, JY, 2023) |
| "We evaluated the association between serum uric acid (SUA) and atrial fibrillation (AF) in patients with chronic heart failure (HF)." | 3.79 | Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure. ( Erbay, AR; Tekin, G; Tekin, YK; Turhan, H; Yetkin, E, 2013) |
| " The objective of the present study was determination of incidence of selected risk factors of IHD, such as overweight and obesity, tobacco smoking, arterial hypertension, type 2 diabetes mellitus, dyslipidaemia, and elevated serum concentration of uric acid." | 3.72 | Selected risk factors of ischemic heart disease in Polish seafarers. Preliminary report. ( Filikowski, J; Renke, W; Rzepiak, M; Smolińska, D; Winnicka, A, 2003) |
| "Acetaminophen was administered acutely at the onset of reperfusion after 20 min of low-flow, global myocardial ischemia in isolated, perfused guinea pig hearts (Langendorff) to evaluate its influence in the postischemia, reperfused myocardium." | 3.71 | Acetaminophen in the post-ischemia reperfused myocardium. ( Golfetti, R; Merrill, G; Rork, T; Spiler, N; VanDyke, K, 2002) |
| "Comparison of the serum uric acid levels of healthy people (n=71) and patients with cardiovascular diseases (CVD) (n=62)." | 3.70 | Serum uric acid levels in cardiovascular diseases. ( Burgaz, S; Simsek, B; Torun, M; Yardim, S, 1998) |
| " The serum concentrations of hypoxanthine, xanthine, uric acid and allantoin were determined in peripheral blood samples from patients with angina pectoris, cerebral insult and myocardial infarction with thrombolytic therapy and were compared with the concentrations obtained for healthy males and females." | 3.69 | A comparative study of the concentrations of hypoxanthine, xanthine, uric acid and allantoin in the peripheral blood of normals and patients with acute myocardial infarction and other ischaemic diseases. ( Delvoux, B; Greiling, H; Kock, R; Sigmund, M, 1994) |
| "Guizhi-Fuling (GZFL) is effective in treating Myocardial ischemia." | 1.72 | Integrated Metabolomics and Network Pharmacology to Reveal the Mechanisms of Guizhi-Fuling Treatment for Myocardial Ischemia. ( Duan, B; Han, L; Huang, F; Li, J; Wang, Q; Ye, Y; Yu, X; Zeng, X; Zhou, Z, 2022) |
| "Uric acid is a purine degradation product but also an important antioxidant and reactive oxygen species (ROS) scavenger." | 1.56 | Human concentrations of uric acid scavenges adaptive and maladaptive reactive oxygen species in isolated rat hearts subjected to ischemic stress. ( Boardman, NT; Chu, X; Falck, AT; Jenssen, TG; Lund, T; Martin-Armas, M; Norvik, JV; Ytrehus, K, 2020) |
| "Hyperlipidemia provokes inversion of correlation between the levels of uric acid, apo-E and apo-C3." | 1.34 | [Uric acid, apo-E and apo-C3 correlation in normo- and hyperlipidemia]. ( Boĭko, ER; Boĭko, SG; Kaneva, AM; Ovechkin, AO; Potolitsyna, NN, 2007) |
| " However, the concomitant production of superoxide and other reactive oxygen species (ROS) during I/R may diminish the bioavailability of NO and hence compromise the beneficial effects." | 1.33 | Prevention of postischemic myocardial reperfusion injury by the combined treatment of NCX-4016 and Tempol. ( Colantuono, G; Khan, M; Kumbala, D; Kuppusamy, P; Kutala, VK; Mandal, R; Potaraju, V, 2006) |
| "Hypertension was the most common followed infrequency by dyslipidemia, diabetes mellitus, ischemic heart disease, and chronic obstructive pulmonary disease consecutively." | 1.32 | Clinical manifestations of patients with hyperuricemia. ( Akkasilpa, S; Avihingsanon, Y; Hanvivadhanakul, P; Wonchinsri, J, 2004) |
| "Deaths due to ischemic heart disease in both men and women increased when serum uric acid levels were in the highest quartile compared with the lowest quartile (men, >416 vs <321 micromol/L; risk ratio, 1." | 1.31 | Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. ( Alderman, MH; Fang, J, 2000) |
| "Hypoxanthine excretion was significantly elevated in patients compared with healthy controls (84." | 1.30 | Urinary hypoxanthine and xanthine levels in acute coronary syndromes. ( Bayindir, O; Boydak, B; Gülter, C; Habif, S; Mutaf, I; Ozmen, D; Senol, B; Turgan, N, 1999) |
| "There were no subjects with ischemic heart disease without the major and secondary risk factors." | 1.29 | Computer classification of screening study of risk factor for ischemic heart disease in 20-60 year old subjects. ( Valkov, Y, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 21 (41.18) | 18.2507 |
| 2000's | 14 (27.45) | 29.6817 |
| 2010's | 11 (21.57) | 24.3611 |
| 2020's | 5 (9.80) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, B | 1 |
| Ye, Y | 1 |
| Zhou, Z | 1 |
| Han, L | 1 |
| Huang, F | 1 |
| Li, J | 1 |
| Wang, Q | 1 |
| Zeng, X | 1 |
| Yu, X | 1 |
| Mackenzie, IS | 1 |
| Hawkey, CJ | 1 |
| Ford, I | 1 |
| Greenlaw, N | 1 |
| Pigazzani, F | 1 |
| Rogers, A | 1 |
| Struthers, AD | 1 |
| Begg, AG | 1 |
| Wei, L | 1 |
| Avery, AJ | 1 |
| Taggar, JS | 1 |
| Walker, A | 1 |
| Duce, SL | 1 |
| Barr, RJ | 1 |
| Dumbleton, JS | 1 |
| Rooke, ED | 1 |
| Townend, JN | 1 |
| Ritchie, LD | 1 |
| MacDonald, TM | 1 |
| Shin, HJ | 1 |
| Yoon, JY | 1 |
| Na, YO | 1 |
| Lee, JK | 1 |
| Kho, BG | 1 |
| Kim, TO | 1 |
| Kim, YI | 1 |
| Lim, SC | 1 |
| Jeong, SH | 1 |
| Kwon, YS | 1 |
| Boardman, NT | 1 |
| Falck, AT | 1 |
| Lund, T | 1 |
| Chu, X | 1 |
| Martin-Armas, M | 1 |
| Norvik, JV | 1 |
| Jenssen, TG | 1 |
| Ytrehus, K | 1 |
| Sandoval-Plata, G | 1 |
| Nakafero, G | 1 |
| Chakravorty, M | 1 |
| Morgan, K | 1 |
| Abhishek, A | 1 |
| Tanaka, Y | 1 |
| Nagoshi, T | 1 |
| Kawai, M | 1 |
| Uno, G | 1 |
| Ito, S | 1 |
| Yoshii, A | 1 |
| Kimura, H | 1 |
| Inoue, Y | 1 |
| Ogawa, K | 1 |
| Tanaka, TD | 1 |
| Minai, K | 1 |
| Ogawa, T | 1 |
| Yoshimura, M | 1 |
| Koza, Y | 1 |
| Simsek, Z | 1 |
| Tas, MH | 1 |
| Palmer, TM | 1 |
| Nordestgaard, BG | 1 |
| Benn, M | 1 |
| Tybjærg-Hansen, A | 1 |
| Davey Smith, G | 1 |
| Lawlor, DA | 1 |
| Timpson, NJ | 1 |
| Tekin, G | 2 |
| Tekin, YK | 2 |
| Kosacka, M | 1 |
| Brzecka, A | 1 |
| Piesiak, P | 1 |
| Korzeniewska, A | 1 |
| Jankowska, R | 1 |
| Aribas, A | 1 |
| Akilli, H | 1 |
| Kayrak, M | 1 |
| Alibasic, H | 1 |
| Yildirim, O | 1 |
| Sertdemir, AL | 1 |
| Karanfil, M | 1 |
| Ozdemir, K | 1 |
| El-Bassossy, HM | 1 |
| Watson, ML | 1 |
| Iwasa, T | 1 |
| Amiya, E | 1 |
| Ando, J | 1 |
| Watanabe, M | 1 |
| Murasawa, T | 1 |
| Komuro, I | 1 |
| Jindrich, S | 1 |
| Ondrej, L | 1 |
| Viktor, M | 1 |
| Zbynek, P | 1 |
| Tomas, P | 1 |
| Ladislav, D | 1 |
| Jiri, V | 1 |
| Lenka, S | 1 |
| Miroslav, S | 1 |
| Bahorun, T | 1 |
| Luximon-Ramma, A | 1 |
| Gunness, TK | 1 |
| Sookar, D | 1 |
| Bhoyroo, S | 1 |
| Jugessur, R | 1 |
| Reebye, D | 1 |
| Googoolye, K | 1 |
| Crozier, A | 1 |
| Aruoma, OI | 1 |
| Kozdağ, G | 1 |
| Ertaş, G | 1 |
| Aygün, F | 1 |
| Emre, E | 1 |
| Kirbaş, A | 1 |
| Ural, D | 1 |
| Soran, O | 1 |
| Erbay, AR | 1 |
| Turhan, H | 1 |
| Yetkin, E | 1 |
| Golfetti, R | 1 |
| VanDyke, K | 1 |
| Rork, T | 1 |
| Spiler, N | 1 |
| Merrill, G | 1 |
| Sitnikova, MIu | 1 |
| Shliakhto, EV | 1 |
| Filikowski, J | 1 |
| Rzepiak, M | 1 |
| Renke, W | 1 |
| Winnicka, A | 1 |
| Smolińska, D | 1 |
| Jee, SH | 1 |
| Lee, SY | 1 |
| Kim, MT | 1 |
| Akkasilpa, S | 1 |
| Avihingsanon, Y | 1 |
| Hanvivadhanakul, P | 1 |
| Wonchinsri, J | 1 |
| Calberg, MJ | 1 |
| Kjøller, E | 1 |
| Baldus, S | 1 |
| Müllerleile, K | 1 |
| Chumley, P | 1 |
| Steven, D | 1 |
| Rudolph, V | 1 |
| Lund, GK | 1 |
| Staude, HJ | 1 |
| Stork, A | 1 |
| Köster, R | 1 |
| Kähler, J | 1 |
| Weiss, C | 1 |
| Münzel, T | 1 |
| Meinertz, T | 1 |
| Freeman, BA | 1 |
| Heitzer, T | 1 |
| Kutala, VK | 1 |
| Khan, M | 1 |
| Mandal, R | 1 |
| Potaraju, V | 1 |
| Colantuono, G | 1 |
| Kumbala, D | 1 |
| Kuppusamy, P | 1 |
| Santos, RD | 1 |
| Nasir, K | 1 |
| Orakzai, R | 1 |
| Meneghelo, RS | 1 |
| Carvalho, JA | 1 |
| Blumenthal, RS | 1 |
| Boĭko, EP | 1 |
| Kaneva, AM | 2 |
| Ovechkin, AO | 2 |
| Potolitsyna, NN | 2 |
| Boĭko, ER | 1 |
| Boĭko, SG | 1 |
| Kock, R | 1 |
| Delvoux, B | 1 |
| Sigmund, M | 1 |
| Greiling, H | 1 |
| Bardenheuer, HJ | 1 |
| Fabry, A | 1 |
| Höfling, B | 1 |
| Peter, K | 1 |
| Finelli, C | 2 |
| Guarnieri, C | 2 |
| Muscari, C | 2 |
| Ventura, C | 1 |
| Caldarera, CM | 2 |
| Stefanelli, C | 1 |
| Flamigni, F | 1 |
| Fukuda, S | 1 |
| Kuzuhara, K | 1 |
| Dobashi, Y | 1 |
| Aikawa, M | 1 |
| Nishimori, H | 1 |
| Inoue, S | 1 |
| Otsubo, O | 1 |
| Inou, T | 1 |
| Mimura, N | 1 |
| Komiyama, N | 1 |
| Nakanishi, M | 1 |
| Matuta, H | 1 |
| Murata, H | 1 |
| Hulsmann, WC | 1 |
| Peschechera, A | 1 |
| Serafini, F | 1 |
| Ferrari, LE | 1 |
| Togashi, R | 1 |
| Koike, T | 1 |
| Valkov, Y | 1 |
| Kupatt, C | 1 |
| Zahler, S | 1 |
| Seligmann, C | 1 |
| Massoudy, P | 1 |
| Becker, BF | 1 |
| Gerlach, E | 1 |
| Yeung, PK | 1 |
| Buckley, SJ | 1 |
| Hung, OR | 1 |
| Pollak, PT | 1 |
| Barclay, KD | 1 |
| Feng, JD | 1 |
| Klassen, GA | 1 |
| Smolenski, RT | 2 |
| Jayakumar, J | 1 |
| Seymour, AM | 1 |
| Yacoub, MH | 2 |
| Zych, M | 1 |
| Makarewicz, W | 1 |
| Mei, DA | 1 |
| Nithipatikom, K | 1 |
| Lasley, RD | 1 |
| Gross, GJ | 1 |
| Torun, M | 1 |
| Yardim, S | 1 |
| Simsek, B | 1 |
| Burgaz, S | 1 |
| Wisłowska, M | 1 |
| Sypuła, S | 1 |
| Kowalik, I | 1 |
| Hoeper, MM | 1 |
| Hohlfeld, JM | 1 |
| Fabel, H | 1 |
| Saito, D | 1 |
| Shiraki, T | 1 |
| Oka, T | 1 |
| Kajiyama, A | 1 |
| Doi, M | 1 |
| Masaka, T | 1 |
| Turgan, N | 1 |
| Boydak, B | 1 |
| Habif, S | 1 |
| Gülter, C | 1 |
| Senol, B | 1 |
| Mutaf, I | 1 |
| Ozmen, D | 1 |
| Bayindir, O | 1 |
| Fang, J | 1 |
| Alderman, MH | 1 |
| Domański, L | 1 |
| Hosoya, T | 1 |
| Rühle, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Allopurinol in the Treatment of Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Treated by Either PCI or CABG: Pilot Study[NCT03700645] | Phase 4 | 100 participants (Anticipated) | Interventional | 2018-12-01 | Not yet recruiting | ||
| Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases[NCT01248143] | Phase 2/Phase 3 | 300 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for uric acid and Myocardial Ischemia
| Article | Year |
|---|---|
[Uric acid as a marker of pathophysiological mechanisms in patients with cardiovascular disease].
Topics: Biomarkers; Cardiovascular Diseases; Heart Failure; Humans; Myocardial Ischemia; Prognosis; Uric Aci | 2005 |
[Non-drug therapeutics of idiopathic hyperuricemia].
Topics: Alcohol Drinking; Diet Therapy; Exercise Therapy; Humans; Microvascular Angina; Myocardial Ischemia; | 1996 |
[Multiple risk factor syndrome and hyperuricemia].
Topics: Female; Humans; Hyperlipidemias; Hypertension; Male; Myocardial Ischemia; Obesity; Risk Factors; Uri | 2001 |
[Hyperuricemia and gout].
Topics: Arthritis, Gouty; Energy Metabolism; Gout; Humans; Kidney Calculi; Myocardial Ischemia; Risk Factors | 1992 |
5 trials available for uric acid and Myocardial Ischemia
| Article | Year |
|---|---|
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
Topics: Aged; Allopurinol; Coronary Artery Disease; Female; Gout; Humans; Male; Myocardial Infarction; Myoca | 2022 |
Black tea reduces uric acid and C-reactive protein levels in humans susceptible to cardiovascular diseases.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Myocardial Is | 2010 |
Clinical effects of enhanced external counterpulsation treatment in patients with ischemic heart failure.
Topics: Aged; Blood Pressure; Cohort Studies; Counterpulsation; Electrocardiography; Female; Heart Failure; | 2012 |
[Endothelial protection in patients with apparent cardiac failure in long-term therapy by carvedilol].
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Drug Therapy, | 2003 |
[Cortisol levels in blood of persons with acute myocardial ischemia and myocardial infarction].
Topics: Adult; Aged; Ascorbic Acid; Female; Free Radicals; Humans; Hydrocortisone; Leukocyte Count; Male; Ma | 1999 |
42 other studies available for uric acid and Myocardial Ischemia
| Article | Year |
|---|---|
Integrated Metabolomics and Network Pharmacology to Reveal the Mechanisms of Guizhi-Fuling Treatment for Myocardial Ischemia.
Topics: Biomarkers; Class I Phosphatidylinositol 3-Kinases; Drugs, Chinese Herbal; Humans; Metabolomics; Mol | 2022 |
Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment.
Topics: Antitubercular Agents; Female; Humans; Hyperuricemia; Male; Myocardial Ischemia; Retrospective Studi | 2023 |
Human concentrations of uric acid scavenges adaptive and maladaptive reactive oxygen species in isolated rat hearts subjected to ischemic stress.
Topics: Animals; Antioxidants; Humans; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Heart; Mito | 2020 |
Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Comorbidity; Diabetes Mellitus; Female; | 2021 |
Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis.
Topics: Aged; Cardiac Catheterization; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial | 2017 |
Uric acid levels and atrial fibrillation.
Topics: Atrial Fibrillation; Female; Heart Failure; Humans; Male; Myocardial Ischemia; Uric Acid | 2014 |
Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; Denmark; Female; Humans; Hyperuricemia; Male; Mendelia | 2013 |
Response to the letter: uric acid levels and atrial fibrillation.
Topics: Atrial Fibrillation; Female; Heart Failure; Humans; Male; Myocardial Ischemia; Uric Acid | 2014 |
Soluble ligand CD40 and uric acid as markers of atheromatosis in patients with obstructive sleep apnea.
Topics: Adult; Atherosclerosis; Biomarkers; Case-Control Studies; CD40 Ligand; Female; Humans; Hypertension; | 2015 |
Effect of serum uric acid on the positive predictive value of dobutamine stress echocardiography.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Area Under Curve; Biomarkers; Chi-Square Distribution; Do | 2016 |
Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.
Topics: Administration, Oral; Allopurinol; Angiotensin II; Animals; Diet, High-Fat; Electrocardiography; Enz | 2015 |
Different Contributions of Physical Activity on Arterial Stiffness between Diabetics and Non-Diabetics.
Topics: Age Factors; Aged; Ankle Brachial Index; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Exe | 2016 |
The profile and prognosis of patients hospitalised with heart failure. The value of discharge blood pressure amd cholesterol.
Topics: Age Factors; Aged; Blood Pressure; Cholesterol; Chronic Disease; Creatinine; Female; Heart Failure; | 2008 |
Serum uric acid levels are associated with atrial fibrillation in patients with ischemic heart failure.
Topics: Aged; Atrial Fibrillation; Biomarkers; Chronic Disease; Female; Heart Atria; Heart Failure; Humans; | 2013 |
Acetaminophen in the post-ischemia reperfused myocardium.
Topics: Acetaminophen; Animals; Creatine Kinase; Female; Guinea Pigs; Heart; Male; Myocardial Ischemia; Myoc | 2002 |
Selected risk factors of ischemic heart disease in Polish seafarers. Preliminary report.
Topics: Adult; Age Distribution; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Me | 2003 |
Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in men.
Topics: Adult; Age Factors; Aged; Diabetes Mellitus; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Mu | 2004 |
Clinical manifestations of patients with hyperuricemia.
Topics: Age Distribution; Aged; Arthritis, Gouty; Cross-Sectional Studies; Diabetes Mellitus; Female; Humans | 2004 |
Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.
Topics: Aged; Cardiomyopathies; Cardiotonic Agents; Enzyme Inhibitors; Female; Humans; Hypoxanthine; Magneti | 2006 |
Prevention of postischemic myocardial reperfusion injury by the combined treatment of NCX-4016 and Tempol.
Topics: Animals; Aspirin; Creatine Kinase; Cyclic N-Oxides; L-Lactate Dehydrogenase; Myocardial Ischemia; My | 2006 |
Relation of uric acid levels to presence of coronary artery calcium detected by electron beam tomography in men free of symptomatic myocardial ischemia with versus without the metabolic syndrome.
Topics: Brazil; Coronary Artery Disease; Cross-Sectional Studies; Humans; Male; Metabolic Syndrome; Middle A | 2007 |
[Correlation of uric acid, APO-CIII, and apo-E in healthy individuals and patients with coronary heart disease and hypertensive disease].
Topics: Apolipoprotein C-III; Apolipoproteins E; Humans; Hypertension; Male; Myocardial Ischemia; Reference | 2007 |
[Uric acid, apo-E and apo-C3 correlation in normo- and hyperlipidemia].
Topics: Adolescent; Adult; Aged; Apolipoprotein C-III; Apolipoproteins E; Biomarkers; Female; Humans; Hyperl | 2007 |
A comparative study of the concentrations of hypoxanthine, xanthine, uric acid and allantoin in the peripheral blood of normals and patients with acute myocardial infarction and other ischaemic diseases.
Topics: Adult; Allantoin; Creatine Kinase; Female; Humans; Hypoxanthine; Hypoxanthines; Isoenzymes; Male; My | 1994 |
Adenosine: a sensitive marker of myocardial ischaemia in man.
Topics: Adenosine; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Circulation; Coronary Disease; | 1994 |
Incorporation of [14C]hypoxanthine into cardiac adenine nucleotides: effect of aging and post-ischemic reperfusion.
Topics: Adenine Nucleotides; Aging; Animals; Hypoxanthine; Hypoxanthines; Male; Myocardial Ischemia; Myocard | 1993 |
Age-dependent differences of ATP breakdown and ATP-catabolite release in ischemic and reperfused hearts.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aging; Animals; Energy Metabolism; In Vitro Technique | 1993 |
[Study of several risk factors of ischemic heart disease in the last 17 years].
Topics: Adult; Blood Glucose; Blood Pressure; Cholesterol; Humans; Male; Myocardial Ischemia; Risk Factors; | 1993 |
Evaluation of cardiac function of renal transplant patients using stress and rest cardiac pool gated scintigraphy and myocardial scintigraphy with 99mTc-MIBI.
Topics: Adult; Age Factors; Aged; Contrast Media; Exercise Test; Female; Gated Blood-Pool Imaging; Heart; Hu | 1996 |
Release of ischemia in paced rat Langendorff hearts by supply of L-carnitine: role of endogenous long-chain acylcarnitine.
Topics: Aerobiosis; Animals; Cardiac Pacing, Artificial; Carnitine; Cations; Cell Membrane; Cells, Cultured; | 1996 |
Computer classification of screening study of risk factor for ischemic heart disease in 20-60 year old subjects.
Topics: Adult; Blood Glucose; Bulgaria; Computers; Electronic Data Processing; Female; Humans; Lipids; Male; | 1996 |
Nitric oxide mitigates leukocyte adhesion and vascular leak after myocardial ischemia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Catalase; Cell Adhesion; Cell Membrane Permeabili | 1996 |
Effect of diltiazem on plasma concentrations of oxypurines and uric acid.
Topics: Adenosine; Adult; Cardiovascular Agents; Diltiazem; Female; Guanosine; Humans; Hypoxanthine; Inosine | 1997 |
The effects of nucleotide pool on purine production in the postischemic heart.
Topics: Adenosine; Adenosine Triphosphate; Animals; Hypoxanthine; Inosine; Kinetics; Myocardial Ischemia; My | 1998 |
Different mechanism of myocardial nucleotide breakdown during normothermic and hypothermic ischemia.
Topics: Adenosine; Animals; Heart Arrest, Induced; Hypoxanthine; In Vitro Techniques; Inosine; Myocardial Is | 1998 |
Myocardial preconditioning produced by ischemia, hypoxia, and a KATP channel opener: effects on interstitial adenosine in dogs.
Topics: Adenine Nucleotides; Adenosine; Animals; Benzopyrans; Dihydropyridines; Dogs; Extracellular Space; H | 1998 |
Serum uric acid levels in cardiovascular diseases.
Topics: Adult; Aged; Cardiovascular Diseases; Coronary Artery Disease; Female; Humans; Lipoproteins; Male; M | 1998 |
Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease.
Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Glucose; Echocardiography; Electrocardiography; Electrocar | 1998 |
Hyperuricaemia in patients with right or left heart failure.
Topics: Adult; Aged; Arthritis, Gouty; Cardiomyopathy, Dilated; Diuretics; Female; Hemodynamics; Humans; Hyp | 1999 |
Morphologic correlation between atherosclerotic lesions of the carotid and coronary arteries in patients with angina pectoris.
Topics: Aged; Angina Pectoris; Arteriosclerosis; Blood Pressure; C-Reactive Protein; Carotid Artery Diseases | 1999 |
Urinary hypoxanthine and xanthine levels in acute coronary syndromes.
Topics: Acute Disease; Adult; Aged; Angina, Unstable; Biomarkers; Blood Urea Nitrogen; Creatine; Female; Hum | 1999 |
Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.
Topics: Adult; Aged; Analysis of Variance; Black or African American; Cardiovascular Diseases; Cross-Section | 2000 |